Doctor profile · Federal record
Dr. WENLI GAO, M.D.
Hematology & Oncology Physician (CMS: HEMATOLOGY/ONCOLOGY) · DANBURY, CT
- NPI 1457611196
- Accepts Medicare
- MIPS 89.1 / 100 · 2023
- 24 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
95 LOCUST AVE
DANBURY, CT 068106148
(203) 739-7029
Credentials & registration
- NPI registered
- May 2012 — 14 yrs on file
- Profile last updated
- September 12, 2016
- Year of graduation
- 2002 — 24 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State license (1)
- Connecticut #55590
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1457611196. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
1,776
Distinct HCPCS
10
Medicare allowed
$143,272
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 472 | 252 | $96 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 407 | 124 | $136 | |
85025 |
Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | 405 | 122 | $8 | |
36415 |
Insertion of needle into vein for collection of blood sample | 174 | 110 | $8 | |
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 66 | 23 | $84 | |
99195 |
Drawing of blood for a medical problem | 65 | 16 | $108 | |
99222 |
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 45 | 43 | $138 | |
99233 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | 41 | 15 | $126 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 31 | 22 | $192 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 29 | 29 | $178 |
In context: peer comparison
Among 6 peers in this city , average services per provider: 141. This provider delivers 13× the peer median.Open Payments
Industry payments received
All-time total
$2,402
Transactions
78
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| ABBVIE INC. | 12 | $266.87 | |
| AstraZeneca Pharmaceuticals LP | 9 | $221.57 | |
| Novartis Pharmaceuticals Corporation | 8 | $200.18 | |
| E.R. Squibb & Sons, L.L.C. | 7 | $170.72 | |
| Rigel Pharmaceuticals, Inc. | 5 | $133.43 | |
| PFIZER INC. | 7 | $128.84 | |
| Merck Sharp & Dohme LLC | 5 | $116.98 | |
| Genentech USA, Inc. | 3 | $87.16 | |
| Celgene Corporation | 3 | $77.92 | |
| ARRAY BIOPHARMA INC | 4 | $76.69 | |
| JAZZ PHARMACEUTICALS INC. | 3 | $76.17 | |
| Daiichi Sankyo Inc. | 3 | $61.71 | |
| Lilly USA, LLC | 3 | $60.72 | |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $55.05 | |
| SOBI, INC | 3 | $54.86 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
705
Patients
140
Total drug cost
$1,607,951
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Letrozole | Generic | 158 | 55 | $4,878 |
| Hydroxyurea | Generic | 69 | 19 | $2,259 |
| Xarelto (Rivaroxaban) | Brand | 62 | 14 | $70,726 |
| Revlimid (Lenalidomide) | Brand | 45 | 0 | $764,367 |
| Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim) | Brand | 44 | 0 | $295 |
| Anastrozole | Generic | 43 | 16 | $1,243 |
| Imbruvica (Ibrutinib) | Brand | 43 | 0 | $711,099 |
| Tamoxifen Citrate | Generic | 37 | 12 | $1,907 |
| Eliquis (Apixaban) | Brand | 35 | 0 | $33,149 |
| Exemestane | Generic | 35 | 11 | $8,634 |